BRIEF-Fate Therapeutics issues U.S.patent protecting hematopoietic stem cell

* Fate Therapeutics announces issuance of U.S. patent protecting enhanced hematopoietic stem cell compositions Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.